Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution . Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Byetta (Exenatide).
|Published (Last):||6 November 2007|
|PDF File Size:||3.67 Mb|
|ePub File Size:||8.72 Mb|
|Price:||Free* [*Free Regsitration Required]|
Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed.
No placebo-treated patients withdrew due to byetta package insert or vomiting. Use with caution with medications that have a narrow therapeutic index or require rapid gastrointestinal absorption. The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness. The most frequently reported byetta package insert reactions leading to withdrawal for Byetta-treated patients packagge nausea 5.
If pancreatitis is suspected, BYETTA should be discontinued byetta package insert and should not be restarted if pancreatitis is confirmed.
This product information is intended for US Healthcare Professionals only. BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, based on postmarketing data. You are encouraged to report negative side byetta package insert of prescription drugs to the FDA. Postmarketing reports of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin. Tell your healthcare provider if you have or had kidney problems or a kidney transplant.
BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
All other trademarks are property of their respective owners. Patients may develop antibodies to exenatide. The Double B logo is a trademark of the AstraZeneca byetta package insert of companies. Oral medications dependent on threshold psckage for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA.
BYETTA slows gastric emptying and can reduce the extent and rate of absorption of orally administered drugs. AstraZeneca provides this link as a service to website visitors. This site is intended for US Consumers. Glucagon-like peptide-1 receptor agonist or bolus insulin with optimized basal insulin in type 2 byetta package insert.
Go to Healthcare Professional Site. Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise. Your risk byetta package insert getting low blood sugar hypoglycemia is higher if you take BYETTA with another byetta package insert that can cause low blood sugar, such as a sulfonylurea or insulin.
Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema. No clinical studies establishing conclusive evidence of macrovascular risk reduction with BYETTA or any other antidiabetic drug. BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
You may give other people a serious infection, or get a serious infection from them. Because exenatide is commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients with severe gastrointestinal disease eg gastroparesis. BYETTA should not be used in people with type 1 diabetes or people with diabetic ketoacidosis a condition caused by very high blood sugar.
byetta package insert
Type 2 Diabetes Medication | BYETTA® (exenatide) injection
Stop taking BYETTA and call your healthcare provider right away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going from your abdomen through to your back.
Pen-sharing poses a risk for transmission of blood-borne pathogens, even if the needle is changed. Based on animal byetta package insert, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The site you are about to visit is maintained by a third party who is solely responsible for byetta package insert contents.
Write your html here Should not be used in patients with severe renal impairment or end-stage renal disease. Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and byetta package insert hemorrhagic packagd necrotizing pancreatitis.
Welcome to BYETTA.com!
Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth. Use of twice-daily exenatide in basal insulin—treated patients with type 2 diabetes: Use with caution in byetta package insert with renal transplantation or when initiating or escalating the dose in patients with moderate renal failure.
Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal failure, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation.
If worsening of byetta package insert failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy.